Baicalein 7-O-glucuronide inhibits FXR-CYP7A1-mediated bile acid signaling in T2DM mice, reducing lipid accumulation in the liver and bile, thus exerting anti-diabetic effects (Yan et al., 2022). Here, CYP7A1 is linked to type 2 diabetes mellitus.